Ulcerative colitis (UC) is a chronic intermittent relapsing disorder of the large intestine and rectum. Treatment typically begins with conventional agents (e.g., 5-aminosalicylic acids [5-ASAs])…
The HIV therapy market is crowded with many approved antiretroviral therapies (ARVs). Growth in this market is being driven by the increasing acceptance of new, high-priced ARVs, particularly the…
Several effective anti-inflammatory agents and bronchodilators are available for controlling mild or moderate asthma. However, despite the availability of long-acting muscarinic antagonists (LAMAs…
Clarivate Epidemiology’s coverage of vitiligo comprises epidemiological estimates of key patient populations in 45 countries. We report diagnosed prevalence of vitiligo for each country, as well…
Clarivate Epidemiology’s coverage of vitiligo comprises epidemiological estimates of key patient populations in 45 countries. We report diagnosed prevalence of vitiligo for each country, as well…
Clarivate Epidemiology’s coverage of vitiligo comprises epidemiological estimates of key patient populations in 45 countries. We report diagnosed prevalence of vitiligo for each country, as well…
Clarivate Epidemiology’s coverage of vitiligo comprises epidemiological estimates of key patient populations in 45 countries. We report diagnosed prevalence of vitiligo for each country, as well…
Clarivate Epidemiology’s coverage of vitiligo comprises epidemiological estimates of key patient populations in 45 countries. We report diagnosed prevalence of vitiligo for each country, as well…
Clarivate Epidemiology’s coverage of vitiligo comprises epidemiological estimates of key patient populations in 45 countries. We report the diagnosed prevalence of vitiligo for each country, as…
Clarivate Epidemiology’s coverage of vitiligo comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the diagnosed prevalence of vitiligo for each…
Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key vitiligo patient populations covering 171 countries and more than 99…